Zhenshu S. Xu

Fujian Provincial Key Laboratory On Hematology, Fujian Medical University Union Hospital
Fuzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Effects of Fibrinogen Levels on Thromboelastography-Derived Clot Strength in Pregnant Women With or Without Immune Thrombocytopenia.

Effects of Fibrinogen Levels on Thromboelastography-Derived Clot Strength in Pregnant Women With or Without Immune Thrombocytopenia.

Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Published: February 17, 2026

Burden of haematological malignancies among children, adolescents and young adults: Global and high-income region insights from the GBD 2021 study.

Burden of haematological malignancies among children, adolescents and young adults: Global and high-income region insights from the GBD 2021 study.

Journal: British journal of haematology

Published: September 16, 2025

Blinatumomab combined with low-dose chemotherapy and tyrosine kinase inhibitors as first-line induction for newly diagnosed Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia: improved efficacy and reduced toxicity.

Blinatumomab combined with low-dose chemotherapy and tyrosine kinase inhibitors as first-line induction for newly diagnosed Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia: improved efficacy and reduced toxicity.

Journal: Frontiers in medicine

Published: August 17, 2025

Exploration of biomarkers for predicting the prognosis of patients with diffuse large B-cell lymphoma by machine-learning analysis.

Exploration of biomarkers for predicting the prognosis of patients with diffuse large B-cell lymphoma by machine-learning analysis.

Journal: BMC immunology

Published: January 22, 2025

BCMA-targeted therapies for multiple myeloma: latest updates from 2024 ASH annual meeting.

BCMA-targeted therapies for multiple myeloma: latest updates from 2024 ASH annual meeting.

Journal: Journal of hematology & oncology

Published: December 19, 2024

Improved CAR internalization and recycling through transmembrane domain optimization reduces CAR-T cytokine release and exhaustion.

Improved CAR internalization and recycling through transmembrane domain optimization reduces CAR-T cytokine release and exhaustion.

Journal: Frontiers in immunology

Published: November 20, 2024

A novel prognostic model utilizing TMTV and SUVmax from 18F-FDG PET/CT for predicting overall survival in patients with extranodal NK/T- cell lymphoma.

A novel prognostic model utilizing TMTV and SUVmax from 18F-FDG PET/CT for predicting overall survival in patients with extranodal NK/T- cell lymphoma.

Journal: BMC cancer

Published: November 13, 2024

Correction: Arsenic trioxide and p97 inhibitor synergize against acute myeloid leukemia by targeting nascent polypeptides and activating the ZAKα-JNK pathway.

Correction: Arsenic trioxide and p97 inhibitor synergize against acute myeloid leukemia by targeting nascent polypeptides and activating the ZAKα-JNK pathway.

Journal: Cancer gene therapy

Published: October 21, 2024

ROR1 CAR-T cells and ferroptosis inducers orchestrate tumor ferroptosis via PC-PUFA2.

ROR1 CAR-T cells and ferroptosis inducers orchestrate tumor ferroptosis via PC-PUFA2.

Journal: Biomarker research

Published: October 15, 2024

When Chinese patients with plasma cell disorders encountered the nationwide Omicron outbreak (December 2022): a real-world multicenter and multiregional study.

When Chinese patients with plasma cell disorders encountered the nationwide Omicron outbreak (December 2022): a real-world multicenter and multiregional study.

Journal: Hematology (Amsterdam, Netherlands)

Published: October 07, 2024

The nuclear factor-κ B inhibitor SN50 enhances the efficacy of B-cell maturation antigen-targeted chimeric antigen receptor T-cell therapy.

The nuclear factor-κ B inhibitor SN50 enhances the efficacy of B-cell maturation antigen-targeted chimeric antigen receptor T-cell therapy.

Journal: Haematologica

Published: September 21, 2024

Analysis of early efficacy and immune reconstitution after autologous hematopoietic stem cell transplantation in multiple myeloma.

Analysis of early efficacy and immune reconstitution after autologous hematopoietic stem cell transplantation in multiple myeloma.

Journal: Scientific reports

Published: July 21, 2024

Showing 1-12 of 33

Last Updated: 09/26/2026